Gabriela Bleiber

1.8k total citations
24 papers, 1.5k citations indexed

About

Gabriela Bleiber is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Gabriela Bleiber has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 13 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Gabriela Bleiber's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Gabriela Bleiber is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Gabriela Bleiber collaborates with scholars based in Switzerland, United Kingdom and Czechia. Gabriela Bleiber's co-authors include Amalio Telenti, Thierry Buclin, Hansjakob Furrer, Margalida Rotger, Raquel Martínez, Sara Colombo, Laurent A. Décosterd, Huldrych F. Günthard, Jérôme Biollaz and Belle L. Lee and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Gabriela Bleiber

23 papers receiving 1.4k citations

Peers

Gabriela Bleiber
Margalida Rotger Switzerland
K. Tsuchiya Japan
Caroline Solas France
Deirdre Egan United Kingdom
Patrick G. Hoggard United Kingdom
Caroline E. Ridgway United Kingdom
John P. Sabo United States
Andrew Mulato United States
Gabriel Birkuš United States
Ivy Song United States
Margalida Rotger Switzerland
Gabriela Bleiber
Citations per year, relative to Gabriela Bleiber Gabriela Bleiber (= 1×) peers Margalida Rotger

Countries citing papers authored by Gabriela Bleiber

Since Specialization
Citations

This map shows the geographic impact of Gabriela Bleiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriela Bleiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriela Bleiber more than expected).

Fields of papers citing papers by Gabriela Bleiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriela Bleiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriela Bleiber. The network helps show where Gabriela Bleiber may publish in the future.

Co-authorship network of co-authors of Gabriela Bleiber

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriela Bleiber. A scholar is included among the top collaborators of Gabriela Bleiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriela Bleiber. Gabriela Bleiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortiz, Millán, Gabriela Bleiber, Raquel Martínez, Henrik Kaessmann, & Amalio Telenti. (2006). Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology. 3(1). 11–11. 40 indexed citations
2.
Goldschmidt, Valérie, Gabriela Bleiber, Margaret May, et al.. (2006). Role of common human TRIM5α variants in HIV-1 disease progression. Retrovirology. 3(1). 54–54. 63 indexed citations
3.
Bashirova, Arman, Gabriela Bleiber, Qi Ying, et al.. (2006). Consistent Effects of TSG101 Genetic Variability on Multiple Outcomes of Exposure to Human Immunodeficiency Virus Type 1. Journal of Virology. 80(14). 6757–6763. 21 indexed citations
4.
May, Margaret, et al.. (2006). Abstract 205, 13th Conference on Retroviruses and Opportunistic Infections Denver, USA.
5.
Colombo, Sara, Nicole Soranzo, Margalida Rotger, et al.. (2005). Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo. Pharmacogenetics and Genomics. 15(9). 599–608. 63 indexed citations
6.
Tarr, Philip, Patrick Taffé, Gabriela Bleiber, et al.. (2005). Modeling the Influence ofAPOC3, APOE,andTNFPolymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid Disorders. The Journal of Infectious Diseases. 191(9). 1419–1426. 90 indexed citations
7.
Rotger, Margalida, Patrick Taffé, Gabriela Bleiber, et al.. (2005). Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia. The Journal of Infectious Diseases. 192(8). 1381–1386. 142 indexed citations
8.
Hasse, Barbara, Huldrych F. Günthard, Gabriela Bleiber, & Martín Krause. (2005). Efavirenz Intoxication Due to Slow Hepatic Metabolism. Clinical Infectious Diseases. 40(3). e22–e23. 52 indexed citations
9.
Rotger, Margalida, Sara Colombo, Hansjakob Furrer, et al.. (2005). Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenetics and Genomics. 15(1). 1–5. 330 indexed citations
10.
Eap, Chin B., Jacques Fellay, Thierry Buclin, et al.. (2004). CYP3A activity measured by the midazolam test is not related to 3435 C>T polymorphism in the multiple drug resistance transporter gene. Pharmacogenetics. 14(4). 255–260. 27 indexed citations
11.
Fischer, Marek, Béda Joos, Bernard Hirschel, et al.. (2004). Cellular Viral Rebound after Cessation of Potent Antiretroviral Therapy Predicted by Levels of Multiply Spliced HIV‐1 RNA Encodingnef. The Journal of Infectious Diseases. 190(11). 1979–1988. 53 indexed citations
12.
Bleiber, Gabriela, Margaret May, Carlos F. Suárez, et al.. (2004). MDR1Genetic Polymorphism Does Not Modify either Cell Permissiveness to HIV‐1 or Disease Progression before Treatment. The Journal of Infectious Diseases. 189(4). 583–586. 20 indexed citations
13.
Ciuffi, Angela, Miguel Muñoz, Gabriela Bleiber, et al.. (2004). Interactions of Processed Nef (58-206) with Virion Proteins of HIV Type 1. AIDS Research and Human Retroviruses. 20(4). 399–407. 6 indexed citations
14.
Eap, Chin B., Thierry Buclin, Daniele Zullino, et al.. (2004). Oral administration of a low dose of midazolam (75�?g) as an in vivo probe for CYP3A activity. European Journal of Clinical Pharmacology. 60(4). 237–46. 84 indexed citations
15.
An, Ping, Gabriela Bleiber, Priya Duggal, et al.. (2004). APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS. Journal of Virology. 78(20). 11070–11076. 150 indexed citations
16.
Ciuffi, Angela, Gabriela Bleiber, Miguel Muñoz, et al.. (2004). Entry and Transcription as Key Determinants of Differences in CD4 T-Cell Permissiveness to Human Immunodeficiency Virus Type 1 Infection. Journal of Virology. 78(19). 10747–10754. 40 indexed citations
17.
Telenti, Amalio, Raquel Martínez, Miguel Muñoz, et al.. (2002). Analysis of Natural Variants of the Human Immunodeficiency Virus Type 1 gag-pol Frameshift Stem-Loop Structure. Journal of Virology. 76(15). 7868–7873. 47 indexed citations
18.
Bleiber, Gabriela, Miguel Muñoz, Angela Ciuffi, Pascal Meylan, & Amalio Telenti. (2001). Individual Contributions of Mutant Protease and Reverse Transcriptase to Viral Infectivity, Replication, and Protein Maturation of Antiretroviral Drug-Resistant Human Immunodeficiency Virus Type 1. Journal of Virology. 75(7). 3291–3300. 68 indexed citations
19.
Kaufmann, Daniel E., Miguel Muñoz, Gabriela Bleiber, et al.. (2000). Virological and immunological characteristics of HIV treatment failure. AIDS. 14(12). 1767–1774. 26 indexed citations
20.
Telenti, Amalio, et al.. (1999). Heterogeneity in the response to antiretroviral therapy.. IRIS. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margalida Rotger Breakdown of academic impact, for papers by K. Tsuchiya Breakdown of academic impact, for papers by Caroline Solas Breakdown of academic impact, for papers by Deirdre Egan Breakdown of academic impact, for papers by Patrick G. Hoggard Breakdown of academic impact, for papers by Caroline E. Ridgway Breakdown of academic impact, for papers by John P. Sabo Breakdown of academic impact, for papers by Andrew Mulato Breakdown of academic impact, for papers by Gabriel Birkuš Breakdown of academic impact, for papers by Ivy Song
Rankless by CCL
2026